Brief: Lipigon Pharmaceuticals Q1 Net Loss Widens To SEK 9 Mln

Lipigon Pharmaceuticals AB

03/05/2022 07:56

May 3 (Reuters) - Lipigon Pharmaceuticals AB  LPGO.ST :
    * Q1 OPERATING INCOME LOSS SEK 9,029 THOUSAND VERSUS LOSS
SEK
4,885 THOUSAND YEAR AGO
    * Q1 NET REVENUE SEK 0 VERSUS SEK 794 THOUSAND YEAR AGO
    * Q1 NET LOSS SEK 9,016 THOUSAND VERSUS LOSS SEK 4,885
THOUSAND
YEAR AGO

Source text for Eikon:  ID:nBQN8sXdb0 
Further company coverage:  LPGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))